Today I'm speaking with Dr. Mark Pimentel and of course, he's no stranger to anyone in the SIBO community. He's been really instrumental in many IBS and SIBO studies and a lot of research that's been happening over the last few years. I learned about Dr. Pimentel through his book, The New IBS Solution, about 10 years ago. He is the executive director of the Medically Associated Science and Technology program at Cedars-Sinai. He's a professor of medicine at Geffen School of Medicine and associate professor of Cedars-Sinai Medical Center in Los Angeles. He's very active in research and has served as a principal investigator or co-investigator for numerous clinical studies. And of course we know him as the developer or discoverer of the anti-vinculin and anti-CdtB antibodies that predict whether or not you have SIBO or autoimmune IBS. He also discovered the use of Lovastatin for methanogens.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related